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ABSTRACT: The first enantioselective total synthesis of the complex tricarbocyclic sesquiterpenoid periconianone A based on a 
postulated biogenesis is reported. Key elements of the synthetic route include the use of an isopropenyl group as a removable 
directing group for stereoselective synthesis, a sequence featuring a Rh-mediated O-H insertion/[3,3]-sigmatropic rearrangement 
and subsequent α-ketol rearrangement, and a late stage aldol reaction to furnish the complex cage-like framework.  
The architectural complexity of terpenes has fascinated 
scientists for centuries, and the challenges associated with 
their intricate structure have fueled innovation in scientific 
fields from synthetic methodology to enzymology.1 Structural 
diversity in terpene biosynthesis is usually achieved at the 
initial cyclase phase by both polyene cyclizations and cationic 
rearrangements.2 In contrast, the cage-like and rigid carbocy-
clic 6/6/6 framework of periconianone A (1), isolated from 
the endophytic fungus Periconia sp., is biosynthetically pro-
posed to be the result of an unusual late-stage aldol cycliza-
tion of the highly oxidized bicyclic eremophilane precursor A 
(Figure 1).3 Such a C4-C12 linkage is to our knowledge un-
precedented in other sesquiterpenoids and its construction 
involves formation of a motif with two contiguous all-carbon 
quaternary stereocenters, a challenging structural feature in 
organic synthesis.4 The intermediacy of labile β-hydroxy ke-
tone B (R = H), prone to elimination and retro-aldol reactions, 
greatly limits the choice of reagents and renders mimicking 
this late-stage aldol transformation a synthetically exigent 
challenge. The chemical synthesis of periconianone A (1) thus 
fits into the context of our research program on unusual 
biogenetic proposals for natural product synthesis.5 In addi-
tion to its striking structural features, periconianone A (1) 
displays diverse biological activity.3,6 
Another challenge besides the key aldol transformation in 
our synthetic plan is the stereoselective elaboration of the C7 
carbinol unit. Although present in diverse bioactive eremoph-
ilane-type natural products, there has so far been no synthet-
ic strategy addressing the construction of this structural mo-
tif. We approached this synthetic challenge and report herein 
on the first enantioselective total synthesis of periconianone 
A (1) applying an efficient crotyl-O-insertion and formal [2,3]-
Wittig rearrangement sequence (C → D).7 
  
Figure 1. Synthetic strategy to periconianone A (1) inspired by a 
biogenetic hypothesis. 
The synthesis starts from known g-hydroxy carvone (2, pre-
pared from (R)-carvone in two steps),8 which was protected 
with TBSCl to give silyl ether 3. Conjugate addition of methyl 
cuprate to enone 3 and trapping of the resulting enolate was 
conducted at –40°C to give access to TMS enol ether 4 with 
good diastereoselectivity (dr >10:1) and quantitative yield.9 
No conversion of the starting material was observed at lower 
reaction temperatures, whereas higher temperatures led to 
increased formation of the undesired diastereoisomer. Lewis 
acid-catalyzed Michael addition of TMS enol ether 4 to me-
thyl vinyl ketone in the presence of BF3·OEt210 gave the de-
sired diketone 5 in 66 % yield, together with desilylated start-
ing material, which was recycled. The isopropenyl group at C2 
had by now served its role to establish the stereogenic cen-
ters at C4 and C5 and was therefore cleaved by Criegee frag-
mentation:11 ozonolysis of the terminal double bond in 5 and 
subsequent treatment of the formed peroxy acetal interme-
diate with Cu(OAc)2 and FeSO4 triggered the fragmentation to 
yield enone 6. Attempts to remove the isopropenyl group 
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later on after formation of the bicyclic structure, as well as 
treatment of the peroxy acetal intermediate with other rea-
gents reported in the literature (Ac2O, DMAP, Et3N)12 mainly 
led to cleavage of the terminal C=C double bond to form the 
acetyl group at C2. Cyclization of 6 under basic conditions 
yielded mixtures of the desired aldol product and an unde-
sired Michael addition by-product, which prompted us to 
hydrogenate the reactive olefin using Pd/C as a catalyst. In 
fact, selective formation of the desired aldol product was 
achieved by enamine catalysis (pyrrolidine, AcOH), but due to 
its high reactivity, the formed dienone moiety proved to be 
unsuitable for the ensuing steps of the synthesis. Octalone 7 
was isolated as a crystalline solid in 88 % yield over two steps 
after treatment of the diketo intermediate with NaOMe in 
MeOH (Scheme 1). 
Scheme 1. Synthesis of diazoketone 8. 
 
With this short and efficient route for the preparation of 
ample quantities of octalone 7 in hand, the stage was set to 
investigate the key O-H insertion/formal [2,3]-sigmatropic 
rearrangement sequence for installing, after oxidative cleav-
age, the three carbon-fragment to complete the C15 skeleton. 
The required precursor featuring a diazo group at C7 was 
prepared by a two-step protocol,13 as direct diazoketone 
formation under basic conditions had proven unsuccessful. 
Trifluoroacylation was performed quantitatively by treatment 
of the enolate of 7 with trifluoroethyl trifluoroacetate. The 
trifluoroacylated compound was then treated with mesyl 
azide and triethylamine to yield diazoketone 8 in 61 % yield 
over two steps. 
In the presence of Rh2(OAc)4, diazoketone 8 reacted with 
trans-crotyl alcohol in a Rh-catalyzed insertion of the carbe-
noid into the  O-H bond to furnish a-allylated 
a-hydroxyketone 9 in 62 % yield and with a diastereomeric 
ratio of 2:1 (Scheme 2). Initially, we had anticipated isolation 
of the ether as the primary insertion product, which would 
have been amenable to a [2,3]-Wittig rearrangement upon 
treatment with base to form the desired a-hydroxyenone 
10.14 There are hardly any literature precedents for reactions 
of a-diazoketones with allylic alcohols in the presence of 
Rh(II) to form the corresponding a-alkylated 
a-hydroxyketones,15 and application in total synthesis has 
only been reported by Wood and co-workers.16 Mechanistic 
studies revealed that the (Z)-enol intermediates formed upon 
O-H insertion of the carbenoid may subsequently undergo a 
[3,3]-sigmatropic rearrangement instead of ketonization to 
the a-keto ether, and that this fast Claisen rearrangement is 
not catalyzed by Rh.15 Our observations are in line with these 
reports, as the a-keto ether, formed as side product during 
the course of the reaction, did not undergo a 
[3,3]-rearrangement, even after prolonged reaction time. 
Neither did heating of the isolated a-keto ether in the ab-
sence or presence of Rh2(OAc)4 lead to the formation of any 
significant amounts of the expected [3,3]-rearranged product 
9. Furthermore, we were surprised by the moderate dia-
stereoselectivity of 2:1 at C11 in the rearranged carbinol 9, as 
the employed trans-crotyl alcohol contained only 5 % of the 
cis-isomer and we had anticipated the reaction to proceed via 
a concerted sigmatropic and therefore stereospecific process. 
A possible explanation for this observation can be found in a 
report by Ireland and co-workers, who investigated the pref-
erence of chair- and boat-like transition-state geometries in 
the ester enolate Claisen rearrangement.17 Based on Ireland’s 
observations, we suppose that the usually disfavored 
twist-boat transition-state (TS-2, Scheme 2) might be accessi-
ble in this [3,3]-rearrangement, thus enabling the formation 
of both diastereoisomers, which could not be separated by 
column chromatography. 
With the a-ketocarbinol 9 at hand, we investigated the 
[1,2]-allyl shift from C8 to C7 through an a-ketol rearrange-
ment. This reaction, also referred to as an acyloin rearrange-
ment, is a well-established transformation and its synthetic 
application has been considerably expanded since applied in 
the D-ring homoannulation of steroids.18 Nevertheless, its 
application in total synthesis is rare18a,19 and most often unan-
ticipated.16b,20 The a-ketol rearrangement is a reversible pro-
cess and its driving force is formation of the more stable a-
hydroxy carbonyl isomer. Literature examples most often 
involve release of ring strain18 or formation of a more stable 
β-dicarbonyl compound starting from β-hydroxy a-
diketones.16a,d By comparing the thermodynamic properties of 
9 and 10, we hypothesize the driving force to be formation of 
the conjugated enone moiety in 10, a mechanistic possibility 
not previously suggested for this type of rearrangement. 
After extensive screening of various inorganic bases, Lewis 
and Brønsted acids,21 the best results were obtained for the 
reaction of 9/11 (2:1) mediated by Ca(OMe)2 in MeOH at 
room temperature to give access to the a-allylated a-
hydroxyenone 10 in 71 % yield and with fully retained config-
uration at stereocenters C7 and C11. Besides basic or Lewis 
acidic conditions, various metal salts are known to promote 
a-ketol rearrangements.18a However, to the best of our 
knowledge, this is the first example for an a-ketol rearrange-
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ment by a simple and cost-efficient calcium salt. The structure 
of 10 was confirmed by single-crystal X-ray analysis,22 which 
revealed that the undesired diastereoisomer with 
S-configuration at C11 was formed preferentially in the 
Claisen rearrangement. We were delighted to find that with 
cis-crotyl alcohol, the insertion/[3,3]-sigmatropic rearrange-
ment process gave a diastereomeric product mixture of 3:1 in 
favor of the desired isomer 11 with R-configuration at C11. 
This process did not take place at room temperature and the 
mixture of crotyl alcohol and Rh2(OAc)4 had to be heated to 
65°C in toluene or 1,2-dichloroethane, before diazoketone 9 
was slowly added. Treatment of a-ketocarbinol 11 with 
Ca(OMe)2 gave access to the desired a-allylated hydroxye-
none 12 in 70 % yield and, after separation, with a diastere-
omeric ratio of 14:1 in favor of the desired isomer, whose 
structure was confirmed by single-crystal X-ray analysis.22 
Scheme 2. Sequence of Rh-mediated O-H insertion, [3,3]-sigmatropic rearrangement and a-ketol rearrangement for the instal-
lation of the tertiary alcohol at C7.  
 
The endgame involved cleavage of the TBS group of 
a-hydroxyenone 12 and oxidation of the resulting secondary 
OH group by Dess-Martin periodinane (DMP) to afford the 
carbonyl group at C3 (Scheme 3). Ozonolysis of the terminal 
double bond in diketone 13 set the stage for the key aldol 
addition of aldehyde 14.  
Scheme 3. Construction of the 6/6/6 tricarbocyclic frame-
work. 
 
Various basic and acidic conditions only induced a retro-
aldol reaction by cleavage of propanal to form the undesired 
diosphenol. After extensive screening, organic phosphonic 
acids,23 very rarely applied for aldol reactions, were shown to 
mediate the desired aldol addition without significant side 
product formation, even in the presence of the free tertiary 
alcohol at C7. Treatment of aldehyde 14 with diphenyl phos-
phate in toluene at 65°C gave tricycle 15 in 71 % yield and full 
diastereoselectivity. Final oxidation of the C1–C2 bond was 
achieved by selenoxide elimination. a-Selenylation using 
LHMDS and phenylselenyl chloride was followed by oxidation 
with NaIO424 to give periconianone A (1) in 45 % yield. The 
spectroscopic data of the synthetic sample matched those 
reported for the natural product.3 
In this communication, we report on the first total synthe-
sis of periconianone A with a late-stage cyclization event as 
one of the key steps. The biomimetic aldol reaction takes 
place without the need of a protecting group for the tertiary 
alcohol, and in total only one protecting group had to be 
employed to achieve this total synthesis. Additional distinc-
tive features of our approach involve a Criegee fragmentation 
to remove the chiral anchor, as well as a Rh-mediated O-H 
insertion followed by a spontaneous Claisen reaction and an 
a-ketol rearrangement. In particular, this rearrangement 
sequence allowed for the stereoselective installation of the 
C7 carbinol, a problem which has not yet been addressed in 
synthetic endeavors aimed at the preparation of eremoph-
ilane-type natural products. This strategy allows for the con-
cise preparation of other eremophilane-type natural products 
bearing this C7 structural motif and will provide access to 
derivatives of periconianone A (1) for SAR studies. 
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